Literature DB >> 28011505

Association of Inflammasome Components in Background Liver with Poor Prognosis After Curatively-resected Hepatocellular Carcinoma.

Fuminori Sonohara1,2, Yoshikuni Inokawa1,2, Mitsuro Kanda1, Yoko Nishikawa1, Suguru Yamada1, Tsutomu Fujii1, Hiroyuki Sugimoto1, Yasuhiro Kodera1, Shuji Nomoto3,2.   

Abstract

BACKGROUND/AIM: Inflammasomes are multiprotein complexes that evoke key inflammatory cascades. The present study evaluated the influence of inflammasome component expression in non-tumorous tissue on postsurgical hepatocellular carcinoma (HCC) prognosis.
MATERIALS AND METHODS: The expressions of candidate genes were investigated using real-time quantitative reverse-transcription polymerase chain reaction in resected HCC cases. In order to identify potential prognostic factors, statistical analyses were performed for each gene.
RESULTS: The expression of nod-like receptor family, pyrin domain containing 3 (NLRP3), nod-like receptor family, CARD domain containing 4 (NLRC4), and absent in melanoma 2 (AIM2) was significantly higher in corresponding normal tissue (CN) compared to those in HCC. High expression of NLRP3, NLRC4, and caspase 1 (CASP1) in CN was significantly correlated with worse overall survival. Furthermore, multivariate analysis revealed that NLRP3 expression in CN greater than the median was an independent prognostic factor for poorer overall survival.
CONCLUSION: High expression of NLRP3, NLRC4, and CASP1 in background non-tumorous liver is significantly correlated with poor prognosis of patients after resection of HCC. Copyright
© 2017 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Inflammasome; background liver; hepatectomy; hepatocellular carcinoma; prognosis

Mesh:

Substances:

Year:  2017        PMID: 28011505     DOI: 10.21873/anticanres.11320

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Comprehensive Analysis of Prognostic Value and Immune Infiltration of NLRC4 and CASP1 in Colorectal Cancer.

Authors:  Li Peng; Ni Zhu; Dan Wang; Yanhong Zhou; Yifei Liu
Journal:  Int J Gen Med       Date:  2022-06-03

Review 2.  New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.

Authors:  Leonardo Lorente
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

3.  The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure.

Authors:  Xiangying Zhang; Peiling Dong; Lin Xu; Yuan Tian; Huayin Sun; Hongbo Shi; Zhongping Duan; Liyan Chen; Feng Ren
Journal:  BMC Gastroenterol       Date:  2019-08-20       Impact factor: 3.067

4.  Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review.

Authors:  Maryam Dadmanesh; Mohammad Mehdi Ranjbar; Khodayar Ghorban
Journal:  Immunol Lett       Date:  2019-03-01       Impact factor: 3.685

5.  Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer.

Authors:  Xiaojuan Zhao; Jianzhong Liu; Shuzhen Liu; Fangfang Yang; Erfei Chen
Journal:  Cancers (Basel)       Date:  2019-11-04       Impact factor: 6.639

Review 6.  The Emerging Relevance of AIM2 in Liver Disease.

Authors:  Beatriz Lozano-Ruiz; José M González-Navajas
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 7.  Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury.

Authors:  Mónica B Jiménez-Castro; María Eugenia Cornide-Petronio; Jordi Gracia-Sancho; Carmen Peralta
Journal:  Cells       Date:  2019-09-23       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.